RT-302(Revio Therapeutics LLP)
N/A
Report date: 2026/02/12 20:00:14
Base Information
Drug NameRT-302(Revio Therapeutics LLP)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesRevio Therapeutics Llp
China Registration ClassN/A
Develop Information
Active CompaniesRevio Therapeutics Llp
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A